Department of Surgery
University of Wisconsin School of Medicine and Public Health

Specialties

Louise Davies, MD, MS

Professor

  • Division of Endocrine Surgery


Education

  • MD, University of Washington School of Medicine, Seattle, WA
  • MS, Masters of Science - Health Services Research & Health Policy University of Washintgon School of Public Health, Seattle, WA
  • General Surgery Internship, University of Vermont, Burlington, VT
  • Otolaryngology-Head & Neck Surgery Residency, University of Vermont, Burlington, VT and Dartmouth Hitchcock Medical Center, Lebanon, NH
  • Senior fellowship Clinical Research, Robert Wood Johnson Clinical Scholars Program, University of Washington, Seattle, WA
  • Research Grant & Fellowship, Fulbright U.S. Global Research Scholar U.S. Department of State

Clinical Specialties

Dr. Davies is certified by the American Board of Otolaryngology. She specializes in surgical treatment of disorders of the thyroid and parathyroid glands, head and neck cancer, voice and swallowing disorders, and skin cancer. She has a dual appointments in the Department of Surgery – Division of Endocrine Surgery and the Department of Otolaryngology – Division of Head & Neck Surgical Oncology.

Dr. Davies provides a wide range of services including Thyroid Surgery, Thyroidectomy, Thyroid Lobectomy, Total Thyroidectomy, Resection Of Substernal Goiter, Parathyroid Surgery, Minimally Invasive Parathyroidectomy, Central Neck Dissection, Functional Neck Dissection, Modified Radical Neck Dissection, Fine Needle Aspiration (FNA), Neck Ultrasound, Parotidectomy, Vocal Cord Injection, Tracheostomy, Esophageal Dilation, Skin Cancer Reconstruction.

Research Interests

Davies is internationally recognized for her research on the epidemiology of thyroid cancer and its impact on population health. Her current projects focus on de-escalation of thyroid cancer treatment for appropriately selected patients to optimize outcomes while minimizing side effects and risks of treatment; and developing research evidence to optimize the patient experience and support joint decision making between physicians and their patients in healthcare for thyroid and head and neck cancer.

Recent Publications

  • Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study.
    Sajisevi M, Nguyen K, Callas P, Holcomb AJ, Vural E, Davis KP, Thomas CM, Stein JS, Asarkar A, Aulet R, Bell RK, Blasco MA, Bowmaster VB, Burruss CP, Chung J, Chan K, Chang BA, Coffey CS, Cognetti DM, Cooper DJ, Cordero J, Donovan J, Du YJ, Dundar Y, Dedivitis R, Edwards H, Erovic BM, Eskander A, Feinberg PA, Garvey EA, Goldstein D, Goodman JF, Goulart RN, Goyal N, Grasl S, Giurintano J, Gupta N, Habib A, Hackman T, Hara JH, Henson C, Hinni ML, Hua N, Johnson-Obaseki S, Juloori A, Kalman NS, Kejner A, Khaja SF, Ku JA, Lambert A, Luu BK, Magliocca KR, Medina Dos Santos LR, Michael C, Miles B, de Melo GM, Moore MG, Morand GB, Moura K, Noroozi H, Patel R, Paydarfar J, Plonowska-Hirschfeld KA, Sadeghi N, Savaria F, Schmitt NC, Shapiro J, Shaver TB, Stoeckli SJ, Stokes WA, Sulibhavi A, Tasoulas J, Vendra V, Vinh DB, Virgen CG, Woody NM, Young GD, Kakarala K, Enepekides DJ, Hier MP, Davies L, Ryan WR
    Laryngoscope Investig Otolaryngol 2025 Oct; 10(5): e70246
    [PubMed ID: 40995062]

  • Updated Calcitonin Values for Prediction of Lymph Node Metastasis in Medullary Thyroid Cancer.
    Shaha AR, Ganly I, Davies L
    JAMA Otolaryngol Head Neck Surg 2025 Aug 01; 151(8): 767-768
    [PubMed ID: 40569613]

  • Trends in Endovascular Aortic Repair Volume and Surveillance in the Era of the MISSION Act.
    Ponukumati AS, Newton L, Columbo JA, Soybel D, Davies L, Spangler E, Goodney P
    JAMA Surg 2025 Apr 01; 160(4): 465-468
    [PubMed ID: 39693077]

  • Optimizing Face Validity and Clinical Relevance of a Mathematical Population Cancer Epidemiology Model Using a Novel Advisory Group Approach.
    Davies L, Fernandes-Taylor S, Arroyo N, Zhang Y, Alagoz O, Francis DO
    Med Decis Making 2025 May; 45(4): 385-398
    [PubMed ID: 40165387]

  • Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
    Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH, COMET Study Investigators
    JAMA 2025 Mar 18; 333(11): 972-980
    [PubMed ID: 39665585]

All Publications on PubMed